General Information of the Compound
Compound ID
CP0422243
Compound Name
(3S)-3-[4-[[4-[(4-oxospiro[3H-chromene-2,4'-piperidine]-1'-yl)methyl]phenyl]methoxy]phenyl]hex-4-ynoic acid
    Show/Hide
Formula
C33H33NO5
Molecular Weight
523.629
Canonical SMILES
CC#C[C@@H](CC(O)=O)c1ccc(OCc2ccc(CN3CCC4(CC3)CC(=O)c3ccccc3O4)cc2)cc1
    Show/Hide
InChI
InChI=1S/C33H33NO5/c1-2-5-27(20-32(36)37)26-12-14-28(15-13-26)38-23-25-10-8-24(9-11-25)22-34-18-16-33(17-19-34)21-30(35)29-6-3-4-7-31(29)39-33/h3-4,6-15,27H,16-23H2,1H3,(H,36,37)/t27-/m0/s1
    Show/Hide
InChIKey
CEVBGMGJZAYACN-MHZLTWQESA-N
Physicochemical Property
logP
5.8472
Rotatable Bonds
8
Heavy Atom Count
39
Polar Areas
76.07
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
39

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
ChEMBL ID
CHEMBL4799453
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04613, Free fatty acid receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000043 U2OS Homo sapiens (Human)  1
1
EC50 = 2.1 nM
   TI
   LI
   LO
   TS
Protein ID: PT02522, Free fatty acid receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000043 U2OS Homo sapiens (Human)  1
1
EC50 = 4.5 nM
   TI
   LI
   LO
   TS
Protein ID: PT02793, Free fatty acid receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  3
1
EC50 = 8.3 nM
   TI
   LI
   LO
   TS
2
EC50 = 26 nM
   TI
   LI
   LO
   TS
3
EC50 = 65 nM
   TI
   LI
   LO
   TS